IIT research institute:1107221 [18-004523]

Ended Awarded Last action

Contract number
75N95018F00002
Awardee
Awarding agency
Obligated
$271,489

Award facts

Opportunity
Contract value 100% obligated
$271,488.79 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition · 4 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Chicago, IL 60616, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00003 -$55,529
Supplemental Agreement for work within scope P00002 · IIT research institute:1107221 [18-004523] - task order title: "28 day IV toxicity study of axer-204 in rats" $0
Other Administrative Action P00001 $0
Original award $327,018

About this award

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $271,488 delivery order against its CRO Support for NCATS In Vitro and In Vivo Toxicology Studies master IDIQ contract to IIT Research Institute. IIT Research Institute, a division of the Illinois Institute of Technology, will provide in vitro and in vivo toxicology studies support services to NCATS under cost-plus-fixed-fee pricing from June 2018 through August 2019. The prime contractor will perform the work in Chicago, Illinois to assist NCATS in evaluating potential treatments and advancing translational sciences research. No subcontractors or set aside designations were identified.

Quick answers

Who was awarded contract 75N95018F00002?

75N95018F00002 was awarded to IIT Research Institute by National Institute on Drug Abuse (National Institutes of Health) on June 1, 2018.

How much is contract 75N95018F00002 worth?

The government has obligated $271,489 on 75N95018F00002.

Which agency awarded contract 75N95018F00002?

National Institute on Drug Abuse (National Institutes of Health) awarded 75N95018F00002, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).

Is contract 75N95018F00002 an order under another contract?

Yes. 75N95018F00002 is a delivery order under HHSN271201700016I, an indefinite delivery contract, on CRO Support for NCATS In Vitro and In Vivo Toxicology Studies.

Was contract 75N95018F00002 competed?

The extent of competition for 75N95018F00002 was full and open competition. The government received 4 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award